DOI: 10.26717/BJSTR.2017.01.000133
*Corresponding author:
Andrew Korda AM, Royal Prince Alfred Hospital Medical Centre, Level 4, Room 404, 100 Carillon Avenue, Newtown, NSW 2042, AustraliaReceived: June 08, 2017 Published: June 15, 2017
To view the Full Article Peer-reviewed Article PDF
In the last twenty years, we have seen mesh used initially for the treatment of urinary incontinence with great efficacy and for pelvic organ prolapse, which in some women have had a negative impact and unexpected morbidity. This has resulted in issuing of warnings by regulatory authorities [1-5] the voluntary removal of some of these products from the market, adverse publicity in the media and an impending Senate Enquiry.
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China